Sayansan, Raphy P.

HRN: 23-65-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/07/2023
FLUCONAZOLE 50MG (CAP)
09/07/2023
09/14/2023
ORAL
200mg
OD
Oral Candidadiasi; Immunocompromised State
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: